Detalhe da pesquisa
1.
Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent.
Eur J Nucl Med Mol Imaging
; 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372766